Product NDC: | 55390-073 |
Proprietary Name: | Metoprolol Tartrate |
Non Proprietary Name: | Metoprolol Tartrate |
Active Ingredient(s): | 5 mg/5mL & nbsp; Metoprolol Tartrate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-073 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076495 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030717 |
Package NDC: | 55390-073-10 |
Package Description: | 10 VIAL in 1 BOX (55390-073-10) > 5 mL in 1 VIAL |
NDC Code | 55390-073-10 |
Proprietary Name | Metoprolol Tartrate |
Package Description | 10 VIAL in 1 BOX (55390-073-10) > 5 mL in 1 VIAL |
Product NDC | 55390-073 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metoprolol Tartrate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20030717 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | METOPROLOL TARTRATE |
Strength Number | 5 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |